Microvision, Inc. (MVIS) Stock Price & Analysis

Microvision, Inc. (MVIS) fell 8.57% to USD 0.25 as of July 25, 2026 at 15:42 UTC, according to Nexqual real-time market data.

MVIS last closed at USD 0.28; the session ranged USD 0.25–0.28 on volume of 7,519,305 shares. Market capitalization is $86.75M, with a 52-week range of USD 0.25–1.62 (NGM). Source: Nexqual, July 25, 2026 at 15:42 UTC.

Key Statistics (as of July 25, 2026 at 15:42 UTC)

PriceUSD 0.25
Change▼ 8.57% (down)
Previous CloseUSD 0.28
OpenUSD 0.28
Day RangeUSD 0.25 – 0.28
52-Week RangeUSD 0.25 – 1.62
Volume7,519,305 shares
Market Cap$86.75M
ExchangeNGM

Technical Analysis (MVIS)

Nexqual's technical model rates MVIS "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 15:42 UTC.

Overall SignalSELL
RSI (14)33.63 (neutral)
vs SMA50Below (USD 0.42)
MACD-0.04 (negative)

Analyst Ratings (MVIS)

Wall Street analysts rate MVIS "None", per Nexqual as of July 25, 2026 at 15:42 UTC.

Consensus RatingNone
Buy / Hold / Sell1 / 0 / 0

Earnings (MVIS)

Next Earnings Date2026-08-13

Recent Earnings History

QuarterActual vs Estimate
2025-09-30USD -0.05 vs est -0.06 ▲ beat
2025-06-30USD -0.06 vs est -0.07 ▲ beat
2025-03-31USD -0.11 vs est -0.07 ▼ miss

Source: Nexqual, July 25, 2026 at 15:42 UTC.

Financials & Fundamentals (MVIS)

Total Revenue$1.55M
Revenue Growth (YoY)+58.70%
Gross Margin+0.00%
Operating Margin-2213.16%
Profit Margin+0.00%
ROE-197.30%
Debt / Equity135.09
Current Ratio1.05
Total Cash$46.12M
Total Debt$53.42M
Free Cash Flow$-30.87M

Source: Nexqual, July 25, 2026 at 15:42 UTC.

Financial Health Score (MVIS)

Nexqual rates Microvision, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 15:42 UTC.

GrowthCritical — Revenue -74% YoY (annual), sharp decline
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetMixed — $46M cash vs $53M debt
Cash FlowWeak — FCF negative: -$31M, burning cash
EfficiencyCritical — ROE -197%, ROA -41.9%

Ownership (MVIS)

Insider Ownership+1.88%
Institutional Ownership+25.57%
Shares Outstanding344.65M
Float326.46M
Short % of Float+17.12%

Source: Nexqual, July 25, 2026 at 15:42 UTC.

Leadership (MVIS)

Microvision, Inc. is led by Glen W. DeVos (age 63), CEO & Director, per Nexqual as of July 25, 2026 at 15:42 UTC.

CEO & DirectorGlen W. DeVos (age 63)
Interim Chief Financial OfficerStephen Hrynewich (age 58)
Vice President of Product Engineering & OperationsFabio Laura

Major Backers & Investors (MVIS)

Notable institutional backers of Microvision, Inc. include Fidelity, Hudson Bay Capital Management Lp, UBS Group AG, according to Nexqual as of July 25, 2026 at 15:42 UTC.

Active Investors

InvestorStake
Fidelity1.34%
Hudson Bay Capital Management Lp0.9%
UBS Group AG0.74%
MCF Advisors LLC0.7%
Charles Schwab Investment Management, Inc.0.64%

Index Funds (Passive)

FundStake
Vanguard Group12.6%
BlackRock9.05%
State Street2.84%
Geode Capital2.1%
Northern Trust0.69%

Source: Nexqual, July 25, 2026 at 15:42 UTC.

From Microvision, Inc.'s Latest SEC 10-K Filing (filed 2026-03-04)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
OCGNOcugen, Inc.USD 1.21▼ 6.2%
BNGOBionano Genomics, Inc.USD 1.11▼ 0.89%
NNDMNano Dimension Ltd.USD 1.47▼ 0.68%
CLOVClover Health Investments, CorpUSD 4.32▼ 7.49%
SENSSenseonics Holdings, Inc.USD 4.86▲ 0%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:42 UTC. This page is informational and not investment advice.